Genotypic diversity and unrecognized antifungal resistance among populations of Candida glabrata from positive blood cultures
Open accessAbstract
The longstanding paradigm is that most bloodstream infections (BSIs) are caused by a single organism. We performed whole genome sequencing of five-to-ten strains from blood culture (BC) bottles in each of ten patients with Candida glabrata BSI. We demonstrated that BCs contained mixed populations of clonal but genetically diverse strains. Genetically distinct strains from two patients exhibited phenotypes that were potentially important during BSIs, including differences in susceptibility to antifungal agents and phagocytosis. In both patients, the clinical microbiology lab recovered a fluconazole-susceptible index strain, but we identified mixed fluconazole-susceptible and –resistant populations. Diversity in drug susceptibility was likely clinically relevant, as fluconazole-resistant strains were subsequently recovered by the clinical laboratory during persistent or relapsing infections. In one patient, unrecognized respiration-deficient small colony variants were fluconazole-resistant and significantly attenuated for virulence during murine candidiasis. Our data suggest a new population-based paradigm of C. glabrata genotypic and phenotypic diversity during BSIs.
AI snapshot
Written from the paper’s full text.
TL;DR
Whole-genome sequencing of multiple *Candida glabrata* colonies from positive blood cultures in 10 patients showed that each culture contained clonal but genetically diverse strains. In two patients, this diversity included unrecognized fluconazole-resistant subpopulations, including respiration-deficient small colony variants, with differences in antifungal susceptibility, phagocytosis, and virulence.
Key findings
- Across 10 patients, 94 *C. glabrata* blood-culture strains segregated into 4 sequence types and 3 clades; within-patient strains averaged 3,598 nucleotide differences, with the highest in patient J (7,507) and lowest in patient C (2,067).
- In patient L, strain L4 had fluconazole, posaconazole, and isavuconazole MICs ≥8-fold, ≥16-fold, and ≥32-fold higher than other L strains, respectively; it carried a PDR1 G346C substitution, and engineered PDR1 G346C strains had higher azole MICs (256 and 64 μg/mL) than wild-type PDR1 controls (32 and 16 μg/mL).
- In patient J, SCV strains J6–J10 had higher fluconazole and voriconazole MICs (≥64 μg/mL and 16 μg/mL) than NCV strains J1–J4 (4–8 μg/mL and 0.5 μg/mL); SCVs J5 and J9 were more resistant than J1 to neutrophil phagocytosis (12.6±2.7% and 10.9±2.6% vs. 31.8±1.8%) and killing (18.5±8.9% and 22.0±2.4% vs. 39.4±7.7%).
- J9 caused significantly lower tissue burdens than J1 in kidneys and spleens at days 1, 3, and 7 and in livers at day 7 in mice; no mice died by day 21 after injection of either strain.
Methods
- Positive blood culture bottles from 10 patients with *C. glabrata* BSI were streaked, and the clinical index strain plus 4–9 additional colonies per patient underwent Illumina NextSeq whole-genome sequencing; index strains also underwent Oxford Nanopore MinION sequencing.
- Bioinformatic analyses used a Nextflow pipeline with BWA, GATK, SnpEff, BCFTOOLS, FastTree/RAxML, PubMLST, GENOME-STRip, FLYE, Pilon, and progressiveMauve to assess SNPs/indels, phylogeny, sequence types, gene copy-number variants, and mitochondrial copy number.
- Phenotypic assays included CLSI broth dilution antifungal susceptibility testing, qRT-PCR, PDR1 mutant construction, adherence to Hep-2 cells, neutrophil phagocytosis/killing, paraquat killing, respiration/flow cytometry/electron microscopy, and a murine hematogenously disseminated candidiasis model.
Limitations
- The paper states that only 10 strains per blood culture bottle were sequenced, which may not represent the entire *C. glabrata* population; it also states that only first BSI episodes were sequenced, results cannot be extrapolated to other *Candida* spp. or pathogens, and the patients were severely ill with extensive histories, polymicrobial BSIs, and recent antifungal exposure.
- The paper notes that metagenomic sequencing directly from blood might give more comprehensive coverage but is currently limited by low microbial DNA concentrations and difficulty assigning variants to individual strains.
- Evident from the text: detailed phenotypic characterization was performed for strains from only 2 of 10 patients, and the in vitro spiked blood culture experiment used only index strain J1, so the generality of the phenotypic findings remains uncertain.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 26 cited sources checked · 0 supported · 0 flagged
- Findingcitation
PDR1 and CDR1 were up-regulated by 14.6±4.0-fold and 257±11.8-fold, respectively, in strain J9 compared with strain J1.
“As expected from these reports, PDR1 and CDR1 were up-regulated by 14.6±4.0-fold and 257±11.8-fold, respectively, in strain J9 compared with strain J1 (RT-PCR).”
Quote in the paperSubstantial claim - Findingcitation
L4 carried a mutation within PDR1 conferring a G346C substitution within the central regulatory domain of transcriptional regulator Pdr1.
“L4 carried a mutation within PDR1, conferring a G346C substitution within the central regulatory domain of transcriptional regulator Pdr1.17”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] Simonicova L, Moye-Rowley WS. Functional information from clinically-derived drug resistant forms of the Candida glabrata Pdr1 transcription factor. PLoS Genet. 2020; 16(8): e1009005. 32841236 PMC7473514
Not checked in the free run.
- Findingreasoning
Strain J5 was most consistent with a SCV on balance.
“Therefore, on balance, strain J5 was most consistent with a SCV.”
Quote in the paperNot a substantial claim - Findingown data
PDR1 and CDR1 expression were significantly higher in L4 than in other L strains by RT-PCR.
“Using RT-PCR, we showed that PDR1 and CDR1 expression were significantly higher in L4 than in other L strains [Figure 4].”
Quote in the paperSubstantial claim - Findingown data
Within-patient single nucleotide polymorphisms in C. glabrata were not distributed uniformly along the chromosomes but were predominantly clustered in hot spots, particularly in subtelomeric regions.
“Single nucleotide polymorphisms (SNPs) within-patient were not distributed uniformly along the chromosomes, but rather were predominantly clustered in hot spots, particularly in subtelomeric regions [Supplemental Figure 1].”
Quote in the paperNot a substantial claim
- Findingown data
J1 had significantly greater mitochondrial staining with rhodamine-123 than did J9.
“J1 had significantly greater mitochondrial staining with rhodamine-123, as evident by FACS sorting, than did J9 [Figure 5D].”
Quote in the paperNot a substantial claim - Findingown data
Azole MICs were higher against engineered PDR1 G346C strains (256 and 64 μg/mL against L4 and BG2, respectively) than against respective strains with wild-type PDR1 (32 and 16 μg/mL, respectively).
“Azole MICs were higher against the engineered PDR1 G346C strains (256 and 64 μg/mL against L4 and BG2, respectively) than against respective strains with wild-type PDR1 (32 and 16 μg/mL, respectively) [Supplemental Table 3].”
Quote in the paperSubstantial claim - Findingown data
The 94 C. glabrata strains segregated by mitochondrial phylogeny into the same clades as with nuclear phylogeny.
“Overall, the 94 C. glabrata strains were segregated by mitochondrial phylogeny into the same clades as with nuclear phylogeny [Figures 3A].”
Quote in the paperNot a substantial claim - Findingown data
In one patient, unrecognized respiration-deficient small colony variants were fluconazole-resistant and significantly attenuated for virulence during murine candidiasis.
“In one patient, unrecognized respiration-deficient small colony variants were fluconazole-resistant and significantly attenuated for virulence during murine candidiasis.”
Quote in the paperSubstantial claim - Findingown data
Strains J6-J10 showed much higher mitochondrial divergence (DNA identity: 96.71%−99.21%) than did J1-J5 (99.71% - 99.98%).
“Strains J6-J10 showed much higher divergence (DNA identity: 96.71%−99.21%) than did J1-J5 (99.71% - 99.98%).”
Quote in the paperNot a substantial claim - Findingown data
Within-patient gene copy number variants were identified in 4 patients (patients EF, J, H, and K).
“Using a genome assembly and alignment approach with a Nextflow pipeline, we identified within-patient gene copy number variants (CNVs) in 4 patients (patients EF, J, H, and K).”
Quote in the paperNot a substantial claim - Findingown data
Among the 94 C. glabrata strains, SNPs and indels accounted for 89% and 11% of nucleotide differences, respectively.
“Overall, SNPs and indels accounted for 89% and 11% of nucleotide differences, respectively.”
Quote in the paperNot a substantial claim - Findingown data
Estimated mitochondrial genome copy number was significantly higher for J1 than for J9 and J11 (mean 18.4±2.9 vs 0.4±0.1 and 0.3±0.1, respectively; p=0.001, ANOVA).
“Estimated mtN was significantly higher for J1 than for J9 and J11 (mean 18.4±2.9 vs 0.4±0.1 and 0.3±0.1, respectively; p=0.001, ANOVA).”
Quote in the paperSubstantial claim - Findingown data
Fluconazole, posaconazole and isavuconazole MICs against strain L4 were ≥8-fold, ≥16-fold and ≥32-fold higher, respectively, than those against other L strains.
“Fluconazole, posaconazole and isavuconazole MICs against strain L4 were ≥8-fold, ≥16-fold and ≥32-fold higher, respectively, than those against other L strains [Figure 4].”
Quote in the paperSubstantial claim - Findingown data
The average mitochondrial genome copy number for strains from other patients was 28 (range: 24-31 copies).
“The average mtN for strains from other patients was 28 (range: 24–31 copies).”
Quote in the paperNot a substantial claim - Findingown data
Ten strains from randomly selected colonies from the spiked blood culture had growth rates and susceptibility to fluconazole, voriconazole and posaconazole similar to those of strain J1.
“Ten strains from randomly selected colonies had growth rates and susceptibility to fluconazole, voriconazole and posaconazole that were similar to those of strain J1.”
Quote in the paperSubstantial claim - Findingown data
Blood cultures from patient L ~48 hours later, after institution of fluconazole, were fluconazole-resistant.
“Blood cultures ~48 hours later, after institution of fluconazole, were fluconazole-resistant.”
Quote in the paperSubstantial claim - Findingown data
Within-patient C. glabrata strains were clearly divergent based on unique SNPs and/or indels despite high genetic relatedness.
“Despite this genetic relatedness, within-patient strains were clearly divergent, based on unique SNPs and/or indels.”
Quote in the paperSubstantial claim - Findingcitation
Strains J6-J10 and J11 were consistent with small colony variants (respiration-deficient Candida petite mutants) by defective growth in YPD liquid medium, inability to grow on YP-glycerol medium, and deep-violet color on agar containing eosin Y.
“Strains J6-J10 and J11 were consistent with SCVs (i.e., respiration-deficient Candida petite mutants by a constellation of phenotypes, including defective growth in YPD liquid medium, inability to grow on YP-glycerol medium, and deep-violet color on agar containing eosin Y) [Figure 5A and 5B].19”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [19] Cheng S, Clancy CJ, Zhang Z, Uncoupling of oxidative phosphorylation enables Candida albicans to resist killing by phagocytes and persist in tissue. Cell Microbiol. 2007; 9(2): 492– 501. 16987332
Not checked in the free run.
- Findingown data
Within clades, C. glabrata strains clustered by patient.
“Within clades, strains clustered by patient.”
Quote in the paperNot a substantial claim - Findingown data
J strains were significantly enriched for non-synonymous variants in genes involved in mitochondrial functions.
“J strains were also significantly enriched for non-synonymous variants in genes involved in mitochondrial functions.”
Quote in the paperNot a substantial claim - Findingown data
J9 was more resistant to paraquat than J1 (survival rates of 77.0±12.1% at 100mM and 15.5±7.4% at 165mM vs 33.4±12.8% at 100mM and 1.4±0.7% at 165 mM; p=0.0005 and 0.02, respectively).
“J9 was also more resistant to paraquat (survival rates of 77.0±12.1% at 100mM and 15.5±7.4% at 165mM), a redox-active drug that generates endogenous superoxide anions, than J1 (survival rates of 33.4±12.8% at 100mM and 1.4±0.7% at 165 mM; p=0.0005 and 0.02, respectively)”
Quote in the paperSubstantial claim - Findingown data
Genetically distinct strains from two patients exhibited phenotypes potentially important during bloodstream infections, including differences in susceptibility to antifungal agents and phagocytosis.
“Genetically distinct strains from two patients exhibited phenotypes that were potentially important during BSIs, including differences in susceptibility to antifungal agents and phagocytosis.”
- Also stated in: § DISCUSSION · hedged
“In 2 patients, genetically distinct strains exhibited unique phenotypes that were potentially important under antifungal selection pressure and during BSIs, including differences in susceptibility to antifungal agents and phagocytosis.”
Quote in the paperSubstantial claim - Also stated in: § DISCUSSION · hedged
- Findingown data
Gene Ontology term analysis revealed a significant over-representation of genes encoding adhesins and cell wall proteins among non-synonymous mutations that discriminated within-patient strains.
“Gene Ontology (GO) term analysis revealed a significant over-representation of genes encoding adhesins and cell wall proteins [Table 3].”
Quote in the paperNot a substantial claim - Findingown data
Patient J developed intra-abdominal infection due to fluconazole-resistant C. glabrata SCV (strain J11) forty-seven days after BSI.
“Forty-seven days after BSI, he developed intra-abdominal infection due to fluconazole-resistant C. glabrata SCV (strain J11).”
Quote in the paperNot a substantial claim - Findingown data
Two of 10 strains from patient L's initial positive blood culture were fluconazole-resistant.
“Two of 10 strains from the initial positive blood culture were fluconazole-resistant.”
Quote in the paperSubstantial claim - Findingown data
Positive blood cultures from each of ten patients with Candida glabrata bloodstream infection contained mixed populations of clonal but genetically diverse strains that differed by SNPs and, to a lesser extent, insertions, deletions, and presence or absence of specific genes.
“We demonstrated that BCs contained mixed populations of clonal but genetically diverse strains.”
- Also stated in: § DISCUSSION · plain
“We showed that positive blood cultures from each of 10 patients harbored clonal but genetically diverse C. glabrata strains that differed by SNPs and, to a lesser extent, insertions, deletions, and presence or absence of specific genes.”
Quote in the paperSubstantial claim - Also stated in: § DISCUSSION · plain
- Findingown data
In one patient (J), fluconazole-resistant strains were respiration-deficient SCVs, which carried mitochondrial genome mutations that were not present in fluconazole-susceptible, NCV strains.
“In one patient (J), fluconazole-resistant strains were respiration-deficient SCVs, which carried mitochondrial genome mutations that were not present in fluconazole-susceptible, NCV strains.”
Quote in the paperSubstantial claim - Findingown data
Incubation of index strain J1 in a sterile blood culture bottle resulted in significantly fewer nucleotide differences among recovered strains than were observed among J1-J10 (p<0.0001).
“Indeed, incubation of index strain J1 in a sterile blood culture bottle resulted in significantly fewer nucleotide differences among recovered strains than were observed among J1-J10 (p<0.0001)”
Quote in the paperSubstantial claim - Findingown data
The study identified genotypic and phenotypic diversity among C. glabrata from blood cultures of individual patients.
“In conclusion, we identified genotypic and phenotypic diversity among C. glabrata from blood cultures of individual patients.”
Quote in the paperSubstantial claim - Findingown data
Mitochondrial genome phylogeny was less sensitive than WGS phylogeny in identifying within-patient strain diversity.
“On the whole, we found that mitochondrial genome phylogeny was less sensitive than WGS phylogeny in identifying within-patient strain diversity.”
Quote in the paperSubstantial claim - Findingown data
Strains obtained from the spiked blood culture demonstrated significantly fewer nucleotide differences than strains J1-J10 (p<0.0001 for both nuclear and mitochondrial genomes).
“Strains obtained from spiked blood culture demonstrated significantly fewer nucleotide differences than strains J1-J10 (p<0.0001 for both nuclear and mitochondrial genomes).”
Quote in the paperSubstantial claim - Findingown data
SCVs were also not identified by the clinical laboratory during the initial bloodstream infection.
“SCVs were also not identified by the clinical laboratory during the initial BSI.”
Quote in the paperSubstantial claim - Findingown data
Six patients had polymicrobial BSIs that included pathogens in addition to C. glabrata.
“Six patients had polymicrobial BSIs that included pathogens in addition to C. glabrata.”
Quote in the paperNot a substantial claim - Findingown data
Five patients had recent antifungal exposure or breakthrough BSIs while receiving an antifungal agent.
“Moreover, 5 patients had recent antifungal exposure or breakthrough BSIs while receiving an antifungal agent”
Quote in the paperNot a substantial claim - Findingown data
Incubation of index strain J1 in a sterile blood culture bottle did not lead to emergence of SCVs.
“and it did not lead to emergence of SCVs.”
Quote in the paperSubstantial claim - Findingreasoning
The greatest azole resistance and strongest SCV phenotypes were in strains with the most SNPs in mitochondrial genes, regardless of whether they had normal (J6) or reduced (J7-J10) numbers of mitochondria.
“The greatest azole resistance and strongest SCV phenotypes were in strains with the most SNPs in mitochondrial genes, regardless of whether they had normal (J6) or reduced (J7-J10) numbers of mitochondria.”
Quote in the paperSubstantial claim - Interpretationown data
The study's data suggest a new population-based paradigm of C. glabrata genotypic and phenotypic diversity during bloodstream infections.
“Our data suggest a new population-based paradigm of C. glabrata genotypic and phenotypic diversity during BSIs.”
- Also stated in: § DISCUSSION · hedged
“Taken together, our data challenge the long-standing, “single organism” model of pathogenesis, and suggest a new population-based paradigm of C. glabrata genotypic and phenotypic diversity during BSIs.”
Quote in the paperSubstantial claim- Rests on an assumption: The ten enrolled patients are representative of patients with C. glabrata bloodstream infection.
- Also stated in: § DISCUSSION · hedged
- Interpretationown data
Diversity in drug susceptibility was likely clinically relevant because fluconazole-resistant strains were subsequently recovered by the clinical laboratory during persistent or relapsing infections.
“Diversity in drug susceptibility was likely clinically relevant, as fluconazole-resistant strains were subsequently recovered by the clinical laboratory during persistent or relapsing infections.”
- Also stated in: § DISCUSSION · hedged
“Diversity in drug susceptibility was likely clinically relevant, as fluconazole-resistant C. glabrata strains were subsequently recovered by the clinical laboratory during persistent BSI (patient L) or relapsing invasive candidiasis (patient J).”
Quote in the paperSubstantial claim - Also stated in: § DISCUSSION · hedged
- Interpretationreasoning
Azole resistance in SCV strains was associated with growth defects under various conditions in absence of drug exposure, which likely offset potential advantages afforded by evasion of phagocytosis.
“Azole resistance in SCV strains was associated with growth defects under various conditions in absence of drug exposure, which likely offset potential advantages afforded by evasion of phagocytosis.”
Quote in the paperSubstantial claim - Interpretationown data
This is the first study to demonstrate genotypic and phenotypic diversity of Candida in blood cultures of individual patients with bloodstream infection.
“To our knowledge, this is the first study to demonstrate genotypic and phenotypic diversity of Candida in blood cultures of individual patients with BSI.”
Quote in the paperSubstantial claim - Interpretationown data
C. glabrata diversity arising in response to selective pressures during commensalism, including that imposed by antifungal therapy as in several patients here, may result in variant strains that are better able to cause opportunistic infections.
“Our findings suggest that C. glabrata diversity arising in response to selective pressures during commensalism, including that imposed by antifungal therapy as in several patients here, may result in variant strains that are better able to cause opportunistic infections.”
Quote in the paperSubstantial claim - Interpretationreasoning
Genotypic and phenotypic diversity emerged at sites of colonization such as the GI tract prior to bloodstream inoculation.
“We believe that genotypic and phenotypic diversity emerged at sites of colonization such as the GI tract prior to bloodstream inoculation.”
Quote in the paperSubstantial claim - Interpretationown data
Mutations occurring during blood culture incubation are unlikely to account for the extent of within-patient diversity observed in each of the 10 patients.
“While mutations occurring during blood culture incubation may have also contributed to within-patient differences among strains, these are unlikely to account for the extent of diversity we observed in each of our 10 patients.”
Quote in the paperSubstantial claim - Interpretationown data
Data for J strains indicate that mitochondrial genome analysis may be a useful complement to WGS phylogeny for C. glabrata with apparent respiration deficiencies, SCV phenotypes, growth defects or decreased antifungal susceptibility.
“Nevertheless, data for J strains indicate that mitochondrial genome analysis may be a useful complement to WGS phylogeny for C. glabrata with apparent respiration deficiencies, SCV phenotypes, growth defects or decreased antifungal susceptibility.”
Quote in the paperSubstantial claim - Premisecitation
Mitochondrial derangements have been shown to activate the pleiotropic drug resistance Pdr pathway that globally upregulates expression of drug efflux pump genes (e.g., CDR1), leading to azole resistance.
“Mitochondrial derangements have been shown to activate the pleiotropic drug resistance Pdr pathway that globally upregulates expression of drug efflux pump genes (e.g., CDR1), leading to azole resistance17,20,21,35,36.”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [17] Simonicova L, Moye-Rowley WS. Functional information from clinically-derived drug resistant forms of the Candida glabrata Pdr1 transcription factor. PLoS Genet. 2020; 16(8): e1009005. 32841236 PMC7473514
Not checked in the free run.
- cites [20] Siscar-Lewin S, Gabaldon T, Aldejohann AM, Kurzai O, Hube B, Brunke S. Transient Mitochondria Dysfunction Confers Fungal Cross-Resistance against Phagocytic Killing and Fluconazole. mBio. 2021; 12(3): e0112821. 34061590 PMC8262853
Not checked in the free run.
- cites [21] Shingu-Vazquez M, Traven A. Mitochondria and fungal pathogenesis: drug tolerance, virulence, and potential for antifungal therapy. Eukaryot Cell. 2011; 10(11): 1376– 1383. 21926328 PMC3209048
Not checked in the free run.
- cites [35] Hallstrom TC, Moye-Rowley WS. Multiple signals from dysfunctional mitochondria activate the pleiotropic drug resistance pathway in Saccharomyces cerevisiae. J Biol Chem. 2000; 275(48): 37347– 37356. 10980204
Not checked in the free run.
- cites [36] Song J, Zhou J, Zhang L, Li R. Mitochondria-Mediated Azole Drug Resistance and Fungal Pathogenicity: Opportunities for Therapeutic Development. Microorganisms. 2020; 8(10). PMC7600254 33066090
Not checked in the free run.
- Interpretationreasoning
SCVs were likely missed by the clinical laboratory because they were not visualized on blood or SDA agar plates until ≥84 hours after sub-culture.
“SCVs were likely missed by the clinical laboratory because they were not visualized on blood or SDA agar plates until ≥84 hours after sub-culture.”
Quote in the paperSubstantial claim - Premisecitation
Dysfunctional mitochondria activate compensatory responses that confer adaptive advantages with cross-resistance to both azole and phagocytic killing.
“Regardless of mechanism, dysfunctional mitochondria activate compensatory responses that confer adaptive advantages with cross-resistance to both azole and phagocytic killing20,21,35.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [20] Siscar-Lewin S, Gabaldon T, Aldejohann AM, Kurzai O, Hube B, Brunke S. Transient Mitochondria Dysfunction Confers Fungal Cross-Resistance against Phagocytic Killing and Fluconazole. mBio. 2021; 12(3): e0112821. 34061590 PMC8262853
Not checked in the free run.
- cites [21] Shingu-Vazquez M, Traven A. Mitochondria and fungal pathogenesis: drug tolerance, virulence, and potential for antifungal therapy. Eukaryot Cell. 2011; 10(11): 1376– 1383. 21926328 PMC3209048
Not checked in the free run.
- cites [35] Hallstrom TC, Moye-Rowley WS. Multiple signals from dysfunctional mitochondria activate the pleiotropic drug resistance pathway in Saccharomyces cerevisiae. J Biol Chem. 2000; 275(48): 37347– 37356. 10980204
Not checked in the free run.
- Interpretationreasoning
SCV prevalence may be under-estimated unless culture plates are assiduously monitored for several days after Candida growth is detected.
“Therefore, SCV prevalence may be under-estimated unless culture plates are assiduously monitored for several days after Candida growth is detected.”
Quote in the paperSubstantial claim - Premisecitation
The relatively few clinical C. glabrata SCV strains reported to date were recovered from azole-experienced patients.
“In fact, the relatively few clinical C. glabrata SCV strains reported to date were recovered from azole-experienced patients.38,42”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [38] Ferrari S, Sanguinetti M, De Bernardis F, Loss of mitochondrial functions associated with azole resistance in Candida glabrata results in enhanced virulence in mice. Antimicrob Agents Chemother. 2011; 55(5): 1852– 1860. 21321146 PMC3088236
Not checked in the free run.
- cites [42] Brun S, Aubry C, Lima O, Relationships between respiration and susceptibility to azole antifungals in Candida glabrata. Antimicrob Agents Chemother. 2003; 47(3): 847– 853. 12604511 PMC149308
Not checked in the free run.
- Study design and conductnone given
The study sequenced only 10 strains per blood culture bottle, which might not adequately represent the entire C. glabrata population.
“A limitation of this study was that we sequenced only 10 strains per blood culture bottle, which might not adequately represent the entire C. glabrata population.”
Quote in the paperNot a substantial claim - Interpretationown data
Data here and from an earlier investigation of carbapenem resistant K. pneumoniae suggest that genotypic and phenotypic microbial diversity may be especially relevant to BSIs by enteric opportunistic pathogens.
“Data here and from our earlier investigation of carbapenem resistant K. pneumoniae suggest that genotypic and phenotypic microbial diversity may be especially relevant to BSIs by enteric opportunistic”
Quote in the paperNot a substantial claim
- May combine two claims. 32
- The quote only partly states this claim. 1
- Classified as probably not a substantial claim. 20
May combine two claims.
Findingown dataAdherence of strain L2 to Hep-2 cells was significantly higher (91.6±9.2%) than that of either L4 or L6 (66.3±3.4% and 78.0±1.7%, respectively; p=0.03), while L4 and L6 did not significantly differ from each other.
“Adherence of strain L2 to Hep-2 cells was significantly higher (91.6±9.2%) than that of either L4 or L6 (66.3±3.4% and 78.0±1.7%, respectively; p=0.03, Brown-Forsythe ANOVA test); the latter strains did not significantly differ from each other in adherence.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataSCV strains J5 and J9 were more resistant than J1 to neutrophil phagocytosis (12.6±2.7% and 10.9±2.6%, respectively, vs. 31.8 ±1.8; p<0.0001) and killing (18.5±8.9% and 22.0±2.4% vs 39.4.8±7.7; p=0.0007 and 0.0001, respectively).
“SCV strains J5 and J9 were more resistant than J1 to neutrophil phagocytosis (12.6±2.7% and 10.9±2.6%, respectively, vs. 31.8 ±1.8; p<0.0001) and killing (18.5±8.9% and 22.0±2.4% vs 39.4.8±7.7; p=0.0007 and 0.0001, respectively).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataFluconazole and voriconazole MICs were higher against strains J6-J10 (≥64 μg/mL and 16 μg/mL, respectively) than against J1-J4 (4-8 μg/mL and 0.5 μg/mL, respectively); MICs against J5 were intermediate.
“Along these lines, fluconazole and voriconazole MICs were higher against strains J6-J10 (≥ 64 μg/mL and 16 μg/mL, respectively) than they were against J1-J4 (4–8 μg/mL and 0.5 μg/mL, respectively). Fluconazole and voriconazole MICs against J5 (32 μg/mL and 1 μg/mL, respectively) were intermediate to those against the other strains.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOxygen consumption by strain J1 was significantly reduced upon exposure to antimycin A, sodium cyanide or salicylhydroxamic acid (SHAM), whereas oxygen consumption by strain J9 was already diminished in the absence of electron transport inhibition and was not reduced by these inhibitors.
“As expected, oxygen consumption by strain J1 was significantly reduced upon exposure to antimycin A, sodium cyanide or salicylhydroxamic acid (SHAM) [Figure 5F]. In contrast, oxygen consumption by strain J9 was already diminished in the absence of electron transport inhibition, and it was not reduced upon exposure to antimycin A, sodium cyanide or SHAM.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataAfter spiking a sterile blood culture bottle with index strain J1 and incubating for 3 days, sub-cultured colonies were homogenous and consistent with NCVs, with no evidence of SCVs after 5 days.
“After 3 days of incubation, turbidity was observed. Aliquots sub-cultured on SDA plates revealed homogenous colonies consistent with NCVs. There was no evidence of SCVs after 5 days of incubation.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThere were no within-patient gene duplications or large-scale genetic differences such as aneuploidies among the C. glabrata strains.
“There were no within-patient gene duplications or large-scale genetic differences such as aneuploidies.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataJ9 caused significantly lower tissue burdens than J1 in kidneys and spleens at 1, 3 and 7 days, and in livers at 7 days, in mice with hematogenously disseminated candidiasis; none of the mice died at day 21 following injection of 10^7 CFU of either strain.
“None of the mice died at day 21 following lateral tail vein injections of 107 CFU of either strain. J9 caused significantly lower tissues burdens than J1 in kidneys and spleens at 1, 3 and 7 days, and in livers at 7 days [Figure 6]”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataL8 did not carry a PDR1 mutation, but CDR1 expression was increased by >12-fold compared with the index strain L1.
“L8 did not carry a PDR1 mutation, but CDR1 expression was increased by >12-fold compared with the index strain L1.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataTwelve genes were deleted among strains from patients EF, J, H, and K, 8 of which encoded adhesins.
“Twelve genes were deleted among strains from these patients, 8 of which encoded adhesins [Table 2].”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe 94 C. glabrata strains represented 4 sequence types and segregated into three distinct clades: ST3 (patients J, K, P, ST), ST26 (patient H), and ST10 (patients C, D, I, L) plus ST179 (patient EF).
“Strains represented 4 sequence types (STs), and they segregated into three distinct clades: 1) ST3 (patients J, K, P, ST), 2) ST26 (patient H), 3) ST10 (patients C, D, I, L), and ST179 (patient EF) [Figures 2A and B].”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataMitochondrial genome homology among strains from patient J was 96.71%−99.98%, while for other strains within-patient homology was higher (99.69%−100% DNA identity).
“Mitochondrial genome homology (i.e., DNA identity) among strains from patient J was 96.71%−99.98%. For other strains, within-patient homology was higher (99.69%−100% DNA identity).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataOn average, 70.4% and 29.6% of variants were synonymous and non-synonymous, respectively; 99.5% and 0.5% of non-synonymous SNPs were missense and nonsense, respectively.
“On average, 70.4% and 29.6% of variants were synonymous and non-synonymous, respectively; 99.5% and 0.5% of the non-synonymous SNPs were missense and nonsense, respectively.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataOn the mitochondrial phylogenetic tree, strain J11 clustered with SCV strains and was closest to strain J8.
“On mitochondrial phylogenetic tree, strain J11 clustered with SCV strains, and was closest to strain J8 [Figure 7B].”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataEstimated mitochondrial genome copy numbers of J strains ranged from 1 to 35; most SCV strains had ≤18 copies, while strains J1-4 and J6 had 30 and 35 copies, respectively.
“Estimated mtN ranged from 1 to 35. Most SCV strains had ≤18 copies (J9, n=1; J5, n=8; J10, n=13; J7 and J8, n=18). In contrast, estimated mtN for strains J1–4 and J6 were 30 and 35, respectively.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataStrain J11 was a SCV that demonstrated slow growth in YPD media, inability to grow in YP glycerol, small size on SDA plates, purple colonies on eosin plates, and resistance to fluconazole, voriconazole and posaconazole.
“J11 was a SCV that demonstrated slow growth in YPD media, inability to grow in YP glycerol, small size on SDA plates, purple colonies on eosin plates, and resistance to fluconazole, voriconazole and posaconazole.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThere was a within-patient average of 3,598 nucleotide differences across all 10 patients, with J and C strains showing the highest (7,507) and lowest (2,067) within-patient nucleotide differences, respectively.
“There was a within-patient average of 3,598 nucleotide differences across all 10 patients. J and C strains showed the highest (7,507) and lowest (2,067) within-patient nucleotide differences, respectively.”
Quote in the paperSubstantial claimThe quote only partly states this claim.
Findingown dataFluconazole-resistant L strains harbored the PDR1 G346C mutation.
“Resistant strains harbored the PDR1 G346C mutation described above.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataJ11 clustered with other J strains on the nuclear genome phylogenetic tree and was therefore highly related to J strains recovered from the initial blood culture.
“J11 clustered with other J strains on nuclear genome phylogenetic tree [Figure 7A]. Therefore, J11 was highly related to J strains recovered from the initial blood culture.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataPatient L's blood cultures remained positive for C. glabrata ~48 hours after IV fluconazole treatment, and the clinical microbiology laboratory then identified the isolate as azole-resistant.
“Upon diagnosis of fluconazole-susceptible C. glabrata BSI, patient L was treated with IV fluconazole. Blood cultures ~48 hours later remained positive for C. glabrata, which was now identified by the clinical microbiology laboratory as azole-resistant [Table 1].”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn both patients with detailed phenotypic analysis, the clinical microbiology laboratory recovered a fluconazole-susceptible index strain, but mixed fluconazole-susceptible and fluconazole-resistant populations were identified by the study.
“In both patients, the clinical microbiology lab recovered a fluconazole-susceptible index strain, but we identified mixed fluconazole-susceptible and –resistant populations.”
- Also stated in: § DISCUSSION · plain
“In both patients, blood cultures were comprised of mixed fluconazole-susceptible and -resistant populations, but the clinical microbiology laboratory only identified a fluconazole-susceptible index strain.”
Quote in the paperSubstantial claim- Also stated in: § DISCUSSION · plain
May combine two claims.
Findingown dataStrains J1-J5 carried fewer mitochondrial nucleotide differences than did J6-J10, and they clustered in a clade with P, K and ST strains, in keeping with nuclear phylogeny.
“Strains J1-J5 carried fewer mitochondrial nucleotide differences than did J6-J10 [Figure 3B and 3C], and they clustered in a clade with P, K and ST strains, in keeping with nuclear phylogeny.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataUsing site-directed mutagenesis, G346C is a gain-of-function mutation that results in PDR1 hyperactivation and enhanced downstream CDR1 activation.
“Using site-directed mutagenesis, we demonstrated that G346C is a gain-of-function mutation that results in PDR1 hyperactivation and enhanced downstream CDR1 activation.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataCompared to NCV strain J1, SCV strain J9 was relatively resistant to neutrophil phagocytosis and killing, but it was significantly attenuated for virulence in mice with hematogenously disseminated candidiasis.
“Compared to NCV strain J1, SCV strain J9 was relatively resistant to neutrophil phagocytosis and killing, but it was significantly attenuated for virulence in mice with hematogenously disseminated candidiasis.”
Quote in the paperSubstantial claimMay combine two claims.
Findingnone givenNCV strains J1-J4 had normal numbers of mitochondria and few mitochondrial gene mutations.
“NCV strains J1-J4 had normal numbers of mitochondria and few mitochondrial gene mutations.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataPatient J subsequently had a relapsing infection due to a fluconazole-resistant SCV strain (J11) that clustered phylogenetically with SCVs from the initial blood culture.
“Our finding has clinical significance since patient J subsequently had a relapsing infection due to a fluconazole-resistant SCV strain (J11) that clustered phylogenetically with SCVs from the initial blood culture.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Findingown dataTwo patients had invasive candidiasis within the previous 90 days.
“and 2 patients had invasive candidiasis within the previous 90 days.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataAzole-resistant strains from patient J carried wild-type PDR1, but they exhibited SCV phenotypes including slow growth on enriched medium, attenuated proliferation in non-fermentable carbon sources, and mitochondrial and aerobic respiratory defects.
“Azole-resistant strains from patient J carried wild-type PDR1, but they exhibited SCV phenotypes including slow growth on enriched medium, attenuated proliferation in non-fermentable carbon sources, and mitochondrial and aerobic respiratory defects.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
PremisecitationThe longstanding paradigm is that most bloodstream infections, including candidemia, are caused by a population of genetically identical strains derived from a single organism that passes through a bottleneck.
“The longstanding paradigm is that most BSIs, including candidemia, are caused by a population of genetically identical strains derived from a single organism that passes through a bottleneck (“single organism” or “independent action” hypothesis).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [11] Rubin LG. Bacterial colonization and infection resulting from multiplication of a single organism. Rev Infect Dis. 1987; 9(3): 488– 493. 3299635
Not checked in the free run.
- cites [12] Moxon ER, Murphy PA. Haemophilus influenzae bacteremia and meningitis resulting from survival of a single organism. Proc Natl Acad Sci U S A. 1978; 75(3): 1534– 1536. 306628 PMC411507
Not checked in the free run.
Classified as probably not a substantial claim.
PremisecitationPositive blood cultures from individual patients with monomicrobial carbapenem-resistant Klebsiella pneumoniae bloodstream infection were comprised of mixed populations of genetically and phenotypically diverse strains, including differences in antibiotic susceptibility and virulence.
“We recently demonstrated, for the first time, that positive blood cultures from individual patients with monomicrobial bacterial BSI (carbapenem-resistant Klebsiella pneumoniae) were comprised of mixed populations of genetically and phenotypically diverse strains, including those demonstrating differences in antibiotic susceptibility and virulence16.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16] Cheng S, Fleres G, Chen L, Within-Host Genotypic and Phenotypic Diversity of Contemporaneous Carbapenem-Resistant Klebsiella pneumoniae from Blood Cultures of Patients with Bacteremia. mBio. 2022; 13(6): e0290622. 36445082 PMC9765435
Not checked in the free run.
May combine two claims.
PremisecitationPDR1 regulates multidrug transporter gene CDR1, which is linked to fluconazole resistance.
“PDR1 regulates multidrug transporter gene CDR1, which is linked to fluconazole resistance18.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [18] Tsai HF, Krol AA, Sarti KE, Bennett JE. Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants. Antimicrob Agents Chemother. 2006; 50(4): 1384– 1392. 16569856 PMC1426987
Not checked in the free run.
May combine two claims.
PremisecitationAzole exposure has been linked to mitochondrial damage, and patient J received 28 days of fluconazole prophylaxis prior to bloodstream infection.
“Azole exposure has been linked to mitochondrial damage37–41, and patient J received 28 days of fluconazole prophylaxis prior to BSI.”
Quote in the paperNot a substantial claim0 of 5 sources checked- cites [37] Brun S, Berges T, Poupard P, Mechanisms of azole resistance in petite mutants of Candida glabrata. Antimicrob Agents Chemother. 2004; 48(5): 1788– 1796. 15105136 PMC400549
Not checked in the free run.
- cites [38] Ferrari S, Sanguinetti M, De Bernardis F, Loss of mitochondrial functions associated with azole resistance in Candida glabrata results in enhanced virulence in mice. Antimicrob Agents Chemother. 2011; 55(5): 1852– 1860. 21321146 PMC3088236
Not checked in the free run.
- cites [39] Sanglard D, Ischer F, Bille J. Role of ATP-binding-cassette transporter genes in high-frequency acquisition of resistance to azole antifungals in Candida glabrata. Antimicrob Agents Chemother. 2001; 45(4): 1174– 1183. 11257032 PMC90441
Not checked in the free run.
- cites [40] Zhang X, Moye-Rowley WS. Saccharomyces cerevisiae multidrug resistance gene expression inversely correlates with the status of the F(0) component of the mitochondrial ATPase. J Biol Chem. 2001; 276(51): 47844– 47852. 11602584
Not checked in the free run.
- cites [41] Kaur R, Castano I, Cormack BP. Functional genomic analysis of fluconazole susceptibility in the pathogenic yeast Candida glabrata: roles of calcium signaling and mitochondria. Antimicrob Agents Chemother. 2004; 48(5): 1600– 1613. 15105111 PMC400560
Not checked in the free run.
May combine two claims.
Interpretationown dataAzole resistance in various C. glabrata strains from patients L and J was associated with increased expression of transcriptional regulator gene PDR1 and, in turn, up-regulation of efflux gene CDR1.
“Azole resistance in various C. glabrata strains from patients L and J was associated with increased expression of transcriptional regulator gene PDR1 and, in turn, up-regulation of efflux gene CDR1.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductnone givenA strength of the study design is that C. glabrata were collected as blood cultures were being processed according to standard clinical microbiology lab practices.
“A strength of our study design is that C. glabrata were collected as blood cultures were being processed according to standard clinical microbiology lab practices.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Interpretationnone givenThe results cannot be extrapolated to BSIs by other Candida spp. or other pathogens.
“Our results cannot be extrapolated to BSIs by other Candida spp. or other pathogens.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationIn a WGS analysis of C. glabrata from longitudinal cultures of various body sites over 0-90 days, inter-strain genetic variation was primarily due to standing, pre-existing diversity within the population rather than to accumulation of new mutations.
“In a WGS analyses of C. glabrata from longitudinal cultures of various body sites over 0–90 days, investigators previously concluded that inter-strain genetic variation was primarily due to standing, pre-existing diversity within the population rather than to accumulation of new mutations7.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [7] Carrete L, Ksiezopolska E, Gomez-Molero E, Genome Comparisons of Candida glabrata Serial Clinical Isolates Reveal Patterns of Genetic Variation in Infecting Clonal Populations. Front Microbiol. 2019; 10: 112. 30809200 PMC6379656
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
InterpretationreasoningThe extent of diversity detected may reflect particular features of the patients, who were severely ill and had extensive past medical histories.
“The extent of diversity we detected may reflect particular features of our patients, who were severely ill and who had extensive past medical histories (Table 1).”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataSCV strain J9 was less virulent than NCV J1 following intravenous inoculation in the mouse model, but SCVs were able to persist in patient J after resolution of candidemia and re-emerge to cause relapsing infection.
“For example, SCV strain J9 was less virulent than NCV J1 following intravenous inoculation in our mouse model, but nevertheless SCVs were able to persist in patient J after resolution of candidemia and re-emerge to cause relapsing infection.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductown dataCorrect integration of the deletion cassette was verified by PCR.
“Correct integration was verified by PCR.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenAll qRT-PCR experiments were done in independent biological triplicates and are shown as mean with standard deviation for each time point.
“All experiments were done in independent biological triplicates and are shown as mean with standard deviation (SD) for each time point.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe cloned PDR1 sequence was confirmed by Sanger sequencing.
“The cloned PDR1 sequence was confirmed by Sanger sequencing.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThree independent experiments were performed for the respirometry assays.
“Three independent experiments were performed.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe study only sequenced strains from the first episode of BSI.
“We only sequenced strains from the first episode of BSI.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductnone givenC. glabrata were confirmed by matrix assisted laser desorption ionization-time of flight mass spectrometry.
“C. glabrata were confirmed by matrix assisted laser desorption ionization-time of flight mass spectrometry.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationPrevious studies of virulence of C. glabrata SCVs have yielded conflicting results.
“Previous studies of virulence of C. glabrata SCVs have yielded conflicting results.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim.
Study design and conductcitationAntifungal susceptibility testing was performed using the broth dilution technique according to the Clinical and Laboratory Standards Institute (CLSI) standardized method.
“Antifungal susceptibility testing was performed using the broth dilution technique according to the Clinical and Laboratory Standards Institute (CLSI) standardized method62.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [62] Institute CaLS. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard. Fourteh Edition. M27– A3. Wayne, PA.
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenC. glabrata ATCC 90030 was incorporated into each set of antifungal susceptibility experiments as quality control.
“C. glabrata ATCC 90030 was incorporated into each set of experiments as quality control.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationA C. albicans SCV that emerged after hematogenous passage through mouse organs caused lower mortality and acute tissue burdens during disseminated candidiasis than its parent strain, but it persisted within tissue for a prolonged period.
“We previously reported that a C. albicans SCV that emerged after hematogenous passage through mouse organs caused lower mortality and acute tissue burdens during disseminated candidiasis than its parent strain, but it persisted within tissue for a prolonged period19.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] Cheng S, Clancy CJ, Zhang Z, Uncoupling of oxidative phosphorylation enables Candida albicans to resist killing by phagocytes and persist in tissue. Cell Microbiol. 2007; 9(2): 492– 501. 16987332
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenPhagocytosis and killing experiments were performed in triplicate and repeated at least twice.
“The experiments were performed in triplicate and repeated at least twice.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA fluconazole-resistant oropharyngeal C. glabrata SCV was more virulent than an antecedent fluconazole-susceptible strain.
“In another study, however, a fluconazole-resistant oropharyngeal C. glabrata SCV was more virulent than an antecedent fluconazole-susceptible strain38.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [38] Ferrari S, Sanguinetti M, De Bernardis F, Loss of mitochondrial functions associated with azole resistance in Candida glabrata results in enhanced virulence in mice. Antimicrob Agents Chemother. 2011; 55(5): 1852– 1860. 21321146 PMC3088236
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationAn SCV generated by ethidium bromide treatment exhibited reduced virulence during murine disseminated candidiasis.
“In one report, an SCV generated by ethidium bromide treatment exhibited reduced virulence during murine disseminated candidiasis.43”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [43] Brun S, Dalle F, Saulnier P, Biological consequences of petite mutations in Candida glabrata. J Antimicrob Chemother. 2005; 56(2): 307– 314. 15958498
Not checked in the free run.
The paper relies on this without support.
At present, it is unknown whether bloodstream infections are commonly caused by genetically diverse populations rather than single organisms.
“At present, it is unknown if BSIs are commonly caused by genetically diverse populations, rather than single organisms.”
The paper relies on this without support.
Standard microbiology laboratory protocol processes positive clinical cultures by testing single microbial strains from morphologically distinct colonies.
“Standard microbiology laboratory protocol in processing positive clinical cultures is to test single microbial strains from morphologically distinct colonies.”
The paper relies on this without support.
The ten enrolled patients are representative of patients with C. glabrata bloodstream infection.
“We enrolled 10 patients with C. glabrata BSIs [Table 1].”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Petite C. glabrata colonies isolated from blood samples were efficiently cleared in the spleen, liver, and kidney of a systemic infection mouse model.
“petite C. glabrata colonies isolated from blood samples from a recent study were also efficiently cleared in the spleen, liver, and kidney of a systemic infection mouse model (40).”
From Overlooked <i>Candida glabrata</i> petites are echinocandin tolerant, induce host inflammatory responses, and display poor <i>in vivo</i> fitness (2023) · cites this paper as [40]
The Results (Phenotypic diversity of C. glabrata strains; page unavailable) report that the blood-culture-derived small-colony strain J9 produced significantly lower kidney and spleen burdens than J1 on days 1, 3, and 7, and a lower liver burden on day 7. Lower burdens support reduced persistence relative to J1, but the passage does not establish that J9 was efficiently cleared from all three organs. (LLM, conf=0.86)
Experimental — accuracy not yet measuredUnderestimation of petite resulted in fluconazole therapeutic failure and the emergence of pure petite isolates from later blood samples.
“this underestimation of petite resulted in fluconazole therapeutic failure and the emergence of pure petite isolates from later blood samples (40).”
From Overlooked <i>Candida glabrata</i> petites are echinocandin tolerant, induce host inflammatory responses, and display poor <i>in vivo</i> fitness (2023) · cites this paper as [40]
The Discussion (page unavailable) says petite variants may be underestimated because they appear late in culture, and reports a later relapsing infection with a fluconazole-resistant petite variant. It does not say underestimation caused fluconazole treatment failure. The Results, “Patient J” (page unavailable), place the later isolate in an intra-abdominal infection, not a later blood sample; the patient received caspofungin followed by voriconazole prophylaxis. (LLM, conf=0.88)
Experimental — accuracy not yet measuredThe prevalence of petite isolates appeared to be 10% (1/10) in a recent candidemia study exploring the genotypic diversity of C. glabrata colonies growing from the same blood sample.
“The prevalence of petite isolates also appeared to be 10% (1/10) in a recent candidemia study exploring the genotypic diversity of C. glabrata colonies growing from the same blood sample (40).”
From Overlooked <i>Candida glabrata</i> petites are echinocandin tolerant, induce host inflammatory responses, and display poor <i>in vivo</i> fitness (2023) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Ten-strain-per-bottle statement overlooks patient I
MinorThe limitation says 10 strains were sequenced per blood culture bottle, but the strain labels specify only five strains for patient I (the index strain and strains #2-5).
“A limitation of this study was that we sequenced only 10 strains per blood culture bottle, which might not adequately represent the entire C. glabrata population.”
“For each patient, the index strain was labeled as strain #1, and other independently isolated strains were labeled as #2–10 (#2–5 for patient I).”
Cites
RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies
Stamatakis, A. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu033 · Cited by 32,291 · see citing works
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895 · see citing works
Twelve years of SAMtools and BCFtools
Danecek, P., Bonfield, J., Liddle, J., Marshall, J., Ohan, V., Pollard, M., Whitwham, A., Keane, T., McCarthy, S., Davies, R. M., et al. (2021) · GigaScience · doi:10.1093/gigascience/giab008 · Cited by 15,314 · see citing works
FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments
Price, M. N., Dehal, P. S., & Arkin, A. P. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009490 · Cited by 14,894 · see citing works
Cingolani, P., Platts, A., Wang, L. L., Coon, M., Nguyen, T., Wang, L., Land, S. J., Lu, X., & Ruden, D. M. (2012) · Fly · doi:10.4161/fly.19695 · Cited by 11,816 · see citing works
Interactive Tree Of Life (iTOL) v5: an online tool for phylogenetic tree display and annotation
Letunic, I., & Bork, P. (2021) · Nucleic Acids Res. · doi:10.1093/nar/gkab301 · Cited by 9,899 · see citing works
Aligning sequence reads, clone sequences and assembly contigs with BWA-MEMPreprint
Li, H. (2013) · arXiv (Cornell University) · doi:10.48550/arxiv.1303.3997 · Cited by 9,540 · see citing works
Walker, B. J., Abeel, T., Shea, T., Priest, M., Abouelliel, A., Sakthikumar, S., Cuomo, C. A., Zeng, Q., Wortman, J. R., Young, S., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112963 · Cited by 8,994 · see citing works
Assembly of long, error-prone reads using repeat graphs
Kolmogorov, M., Yuan, J., Lin, Y., & Pevzner, P. A. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0072-8 · Cited by 5,986 · see citing works
Nextflow enables reproducible computational workflows
Di Tommaso, P., Chatzou, M., Floden, E. W., Barja, P. P., Palumbo, E., & Notredame, C. (2017) · Nature Biotechnology · doi:10.1038/nbt.3820 · Cited by 4,001 · see citing works
progressiveMauve: Multiple Genome Alignment with Gene Gain, Loss and Rearrangement
Darling, A. E., Mau, B., & Perna, N. T. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011147 · Cited by 3,848 · see citing works
Dujon, B., Sherman, D., Fischer, G., Durrens, P., Casaregola, S., Lafontaine, I., de Montigny, J., Marck, C., Neuvéglise, C., Talla, E., et al. (2004) · Nature · doi:10.1038/nature02579 · Cited by 1,623 · see citing works
Kullberg, B. J., & Arendrup, M. C. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1315399 · Cited by 1,315 · see citing works
Changes in prevalence of health care-associated infections in U.S. hospitals
Magill, S. S., O’Leary, E., Janelle, S. J., Thompson, D. L., Dumyati, G., Nadle, J., Wilson, L. E., Kainer, M. A., Lynfield, R., Greissman, S., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1801550 · Cited by 1,249 · see citing works
Reference method for broth dilution antifungal susceptibility testing of yeasts : Approved standard
Rex, J. H., & Clinical (2008) · Clinical and Laboratory Standards Institute eBooks · Cited by 1,052 · see citing works
D-GENIES: dot plot large genomes in an interactive, efficient and simple way
Cabanettes, F., & Klopp, C. (2018) · PeerJ · doi:10.7717/peerj.4958 · Cited by 797 · see citing works
The SAT1 flipper, an optimized tool for gene disruption in Candida albicans
Reuß, O., Vik, Å., Kolter, R., & Morschhäuser, J. (2004) · Gene · doi:10.1016/j.gene.2004.06.021 · Cited by 744 · see citing works
A <i>Candida auris</i> Outbreak and Its Control in an Intensive Care Setting
Eyre, D. W., Sheppard, A. E., Madder, H., Moir, I., Moroney, R., Quan, T. P., Griffiths, D., George, S., Butcher, L., Morgan, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1714373 · Cited by 517 · see citing works
Within-host evolution of bacterial pathogens
Didelot, X., Walker, A. S., Peto, T., Crook, D. W., & Wilson, D. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2015.13 · Cited by 462 · see citing works
Skrzypek, M. S., Binkley, J., Binkley, G., Miyasato, S. R., Simison, M., & Sherlock, G. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw924 · Cited by 455 · see citing works
Cormack, B. P., Ghori, N., & Falkow, S. (1999) · Science · doi:10.1126/science.285.5427.578 · Cited by 383 · see citing works
Large multiallelic copy number variations in humans
Handsaker, R. E., Doren, V. V., Berman, J. R., Genovese, G., Kashin, S., Boettger, L. M., & McCarroll, S. A. (2015) · Nature Genetics · doi:10.1038/ng.3200 · Cited by 382 · see citing works
The evolution of drug resistance in clinical isolates of Candida albicans.
Ford, C. B., Funt, J. M., Abbey, D., Issi, L., Guiducci, C., Martinez, D. A., Delorey, T., Li, B. Y., White, T. C., Cuomo, C., et al. (2015) · eLife · doi:10.7554/elife.00662 · Cited by 348 · see citing works
Adhesins in human fungal pathogens: glue with plenty of stick.
de Groot, P. W. J., Bader, O., de Boer, A. D., Weig, M., & Chauhan, N. (2013) · Eukaryotic Cell · doi:10.1128/ec.00364-12 · Cited by 319 · see citing works
Molecular Phylogenetics of Candida albicans
Odds, F. C., Bougnoux, M., Shaw, D. J., Bain, J. M., Davidson, A. D., Diogo, D., Jacobsen, M. D., Lecomte, M., Li, S.-Y., Tavanti, A., et al. (2007) · Eukaryotic Cell · doi:10.1128/ec.00041-07 · Cited by 306 · see citing works
The ‘obligate diploid’ Candida albicans forms mating-competent haploids
Hickman, M. A., Zeng, G., Forche, A., Hirakawa, M. P., Abbey, D., Harrison, B. D., Wang, Y.-M., Su, C.-H., Bennett, R. J., Wang, Y., et al. (2013) · Nature · doi:10.1038/nature11865 · Cited by 284 · see citing works
Lieberman, T. D., Flett, K. B., Yelin, I., Martin, T. R., McAdam, A. J., Priebe, G. P., & Kishony, R. (2013) · Nature Genetics · doi:10.1038/ng.2848 · Cited by 270 · see citing works
Evolutionary dynamics of Staphylococcus aureus during progression from carriage to disease
Young, B., Golubchik, T., Batty, E. M., Fung, R., Larner-Svensson, H., Votintseva, A. A., Miller, R. R., Godwin, H., Knox, K., Everitt, R. G., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1113219109 · Cited by 263 · see citing works
Sanglard, D., Ischer, F., & Bille, J. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.4.1174-1183.2001 · Cited by 247 · see citing works
Tsai, H.-F., Krol, A. A., Sarti, K. E., & Bennett, J. E. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.4.1384-1392.2006 · Cited by 237 · see citing works
Shingu-Vazquez, M., & Traven, A. (2011) · Eukaryotic Cell · doi:10.1128/ec.05184-11 · Cited by 209 · see citing works
Hallstrom, T. C., & Moye-Rowley, W. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m007338200 · Cited by 194 · see citing works
Haemophilus influenzae bacteremia and meningitis resulting from survival of a single organism
Moxon, E. R., & Murphy, P. A. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.3.1534 · Cited by 173 · see citing works
Kaur, R., Castaño, I., & Cormack, B. P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1600-1613.2004 · Cited by 167 · cited 1× · see citing works
“It is unclear what precipitated mitochondrial dysfunction and emergence of SCVs. Azole exposure has been linked to mitochondrial damage 40 – 44 , and patient J received 28 days of fl uconazole prior to BSI.”
Zhou, W. L., Spoto, M., Hardy, R., Guan, C., Fleming, E. S., Larson, P. J., Brown, J. S., & Oh, J. (2020) · Cell · doi:10.1016/j.cell.2020.01.006 · Cited by 165 · see citing works
Global analysis of mutations driving microevolution of a heterozygous diploid fungal pathogen
Ene, I. V., Farrer, R. A., Hirakawa, M. P., Agwamba, K., Cuomo, C. A., & Bennett, R. J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806002115 · Cited by 155 · cited 3× · see citing works
“Candida strains often manifest striking genomic plasticity, which is believed to facilitate adaptation and survival under diverse and changing conditions 3 – 10 .”
Mechanisms of Azole Resistance in Petite Mutants of <i>Candida glabrata</i>
Brun, S., Bergès, T., Poupard, P., Vauzelle-Moreau, C., Renier, G., Chabasse, D., & Bouchara, J.-P. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.5.1788-1796.2004 · Cited by 151 · see citing works
Ferrari, S., Sanguinetti, M., De Bernardis, F., Torelli, R., Posteraro, B., Vandeputte, P., & Sanglard, D. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01271-10 · Cited by 144 · cited 2× · see citing works
“Therelatively fewclinical C. glabrata SCVstrainsreportedtodate were recovered from azole-experienced patients 41,45 .”
Variations of Candida albicans electrophoretic karyotypes
Rustchenko-Bulgac, E. P. (1991) · Journal of Bacteriology · doi:10.1128/jb.173.20.6586-6596.1991 · Cited by 132 · see citing works
Carreté, L., Ksiezopolska, E., Pegueroles, C., Gómez-Molero, E., Saus, E., Iraola-Guzmán, S., Loska, D., Bader, O., Fairhead, C., & Gabaldón, T. (2018) · Current Biology · doi:10.1016/j.cub.2017.11.027 · Cited by 118 · see citing works
Timmermans, B., De Las Peñas, A., Castaño, I., & Van Dijck, P. (2018) · Journal of Fungi · doi:10.3390/jof4020060 · Cited by 109 · see citing works
Shields, R. K., Nguyen, M. H., Press, E. G., Updike, C. L., & Clancy, C. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00136-13 · Cited by 105 · see citing works
Self-citationGabaldón, T., & Carreté, L. (2016) · FEMS Yeast Research · doi:10.1093/femsyr/fov110 · Cited by 99 · see citing works
Forche, A., Cromie, G., Gerstein, A. C., Solis, N. V., Pisithkul, T., Srifa, W., Jeffery, E., Abbey, D., Filler, S. G., Dudley, A. M., et al. (2018) · Genetics · doi:10.1534/genetics.118.301019 · Cited by 94 · see citing works
In-vivo selection of an azole-resistant petite mutant of Candida glabrata
BOUCHARA, J.-P., LE BOUDOUIL, S., FILMON, R., ZOUHAIR, R., HALLET, J.-N., CHABASSE, D., RENIER, G., & DEFONTAINE, A. (2000) · Journal of Medical Microbiology · doi:10.1099/0022-1317-49-11-977 · Cited by 88 · see citing works
Targeted Versus Universal Antifungal Prophylaxis Among Liver Transplant Recipients
Eschenauer, G. A., Kwak, E. J., Humar, A., Potoski, B. A., Clarke, L. G., Shields, R. K., Abdel‐Massih, R., Silveira, F. P., Verhidis, P., Clancy, C. J., et al. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12993 · Cited by 86 · see citing works
Self-citationZhang, X., & Moye-Rowley, W. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106285200 · Cited by 84 · see citing works
Bacterial Colonization and Infection Resulting from Multiplication of a Single Organism
Rubin, L. G. (1987) · Clinical Infectious Diseases · doi:10.1093/clinids/9.3.488 · Cited by 77 · see citing works
Biological consequences of petite mutations in Candida glabrata
Brun, S., Dalle, F., Saulnier, P., Renier, G., Bonnin, A., Chabasse, D., & Bouchara, J.-P. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki200 · Cited by 65 · see citing works
Relationships between Respiration and Susceptibility to Azole Antifungals in <i>Candida glabrata</i>
Brun, S., Aubry, C., Lima, O., Filmon, R., Bergès, T., Chabasse, D., & Bouchara, J.-P. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.3.847-853.2003 · Cited by 64 · see citing works
Wang, J. M., Bennett, R. J., & Anderson, M. Z. (2018) · mBio · doi:10.1128/mbio.01205-18 · Cited by 59 · see citing works
Carreté, L., Ksiezopolska, E., Gómez-Molero, E., Angoulvant, A., Bader, O., Fairhead, C., & Gabaldón, T. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00112 · Cited by 58 · see citing works
Genome structure and dynamics of the yeast pathogen Candida glabrata
Ahmad, K. M., Kokošar, J., Guo, X., Gu, Z., Ishchuk, O. P., & Piškur, J. (2014) · FEMS Yeast Research · doi:10.1111/1567-1364.12145 · Cited by 57 · see citing works
Molecular mechanisms of azole resistance in Candida bloodstream isolates
Teo, J. Q.-M., Lee, S. J.-Y., Tan, A., Lim, R. S. M., Cai, Y., Lim, T.-P., & Kwa, A. L. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3672-5 · Cited by 54 · see citing works
Within-Host Genomic Diversity of Candida albicans in Healthy Carriers
Sitterlé, E., Maufrais, C., Sertour, N., Palayret, M., d’Enfert, C., & Bougnoux, M.-E. (2019) · Scientific Reports · doi:10.1038/s41598-019-38768-4 · Cited by 51 · see citing works
Song, J., Zhou, J., Zhang, L., & Li, R. (2020) · Microorganisms · doi:10.3390/microorganisms8101574 · Cited by 50 · see citing works
Cheng, S., Clancy, C. J., Zhang, Z., Hao, B., Wang, W., Iczkowski, K. A., Pfaller, M. A., & Nguyen, M. H. (2006) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00805.x · Cited by 45 · see citing works
Self-citationGerstein, A. C., Lim, H., Berman, J. G., & Hickman, M. A. (2017) · Evolution · doi:10.1111/evo.13205 · Cited by 43 · see citing works
Šimoničová, L., & Moye-Rowley, S. (2020) · PLoS Genetics · doi:10.1371/journal.pgen.1009005 · Cited by 41 · see citing works
MixedCandida albicansstrain populations in colonized and infected mucosal tissues
Jacobsen, M. D., Duncan, A. D., Bain, J. M., Johnson, E. M., Naglik, J. R., Shaw, D. J., Gow, N. A. R., & Odds, F. C. (2008) · FEMS Yeast Research · doi:10.1111/j.1567-1364.2008.00438.x · Cited by 36 · see citing works
Biswas, C., Chen, S. C.-A., Halliday, C., Kennedy, K., Playford, E. G., Marriott, D. J., Slavin, M. A., Sorrell, T. C., & Sintchenko, V. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.03.014 · Cited by 36 · see citing works
Siscar-Lewin, S., Gabaldón, T., Aldejohann, A. M., Kurzai, O., Hube, B., & Brunke, S. (2021) · mBio · doi:10.1128/mbio.01128-21 · Cited by 36 · see citing works
Helmstetter, N., Chybowska, A. D., Delaney, C., Dantas, A. D. S., Gifford, H., Wacker, T., Munro, C. A., Warris, A., Jones, B. L., Cuomo, C. A., et al. (2022) · Genetics · doi:10.1093/genetics/iyac031 · Cited by 29 · see citing works
Moorhouse, A. J., Rennison, C., Raza, M. W., Lilić, D., & Gow, N. A. R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145888 · Cited by 25 · see citing works
Cheng, S., Fleres, G., Chen, L., Liu, G., Hao, B., Newbrough, A., Driscoll, E., Shields, R. K., Squires, K. M., Chu, T., et al. (2022) · mBio · doi:10.1128/mbio.02906-22 · Cited by 23 · see citing works
Self-citationJjj1 Is a Negative Regulator of Pdr1-Mediated Fluconazole Resistance in Candida glabrata
Whaley, S., Caudle, K. E., Šimoničová, L., Zhang, Q., Moye-Rowley, S., & Rogers, P. D. (2018) · mSphere · doi:10.1128/msphere.00466-17 · Cited by 21 · see citing works
Knoll, M. A., Lackner, N., Ulmer, H., Samardzic, E., Steinmann, J., Krause, R., Verhasselt, H. L., Rath, P., Fuchs, F., Koehler, P. A., et al. (2022) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2022.04.014 · Cited by 11 · see citing works
Stefanini, I., Stoakes, E., Wu, H. H. T., Xu-McCrae, L., Hussain, A., Moat, J., Dowson, C. G., David, M. D., & Constantinidou, C. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.01827-22 · Cited by 10 · see citing works
Flagged first, then by citations
1 of the 69 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Candida albicans and Candida glabrata : global priority pathogens
Katsipoulaki, M., Stappers, M. H. T., Malavia, D., Brunke, S., Hube, B., & Gow, N. A. R. (2024) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00021-23 · Cited by 174 · see citing works
Hoenigl, M., Arastehfar, A. A., Arendrup, M. C., Brüggemann, R. J. M., Carvalho, A., Chiller, T. M., Chen, W., Egger, M., Feys, S., Gangneux, J., et al. (2024) · Clinical Microbiology Reviews · doi:10.1128/cmr.00074-23 · Cited by 160 · see citing works
Arastehfar, A., Daneshnia, F., Hovhannisyan, H., Fuentes, D., Cabrera, N., Quinteros, C., Ilkit, M., Ünal, N., Hilmioğlu-Polat, S., Jabeen, K., et al. (2023) · mBio · doi:10.1128/mbio.01180-23 · Cited by 27 · see citing works
One species, many faces: The underappreciated importance of strain diversity
Nysten, J. V., Sofras, D., & Dijck, P. V. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1011931 · Cited by 25 · see citing works
Zajac, C., Scott, N. E., Kline, S., Erayil, S. E., & Selmecki, A. M. (2025) · npj Antimicrobials and Resistance · doi:10.1038/s44259-025-00102-6 · Cited by 19 · see citing works
Maroc, L., Shaker, H., & Shapiro, R. S. (2024) · mSphere · doi:10.1128/msphere.00761-23 · Cited by 20 · see citing works
Resilience in Resistance: The Role of Cell Wall Integrity in Multidrug-Resistant Candida
Banda-Flores, I. A., Torres‐Tirado, D., Mora-Montes, H. M., Pérez‐Flores, G., & Pérez-García, L. A. (2025) · Journal of Fungi · doi:10.3390/jof11040271 · Cited by 15 · see citing works
Naskar, S., Prajapati, A., & Kaur, R. (2025) · FEMS Yeast Research · doi:10.1093/femsyr/foaf025 · Cited by 11 · see citing works
Hassoun, Y., Aptekmann, A. A., Keniya, M. V., Gomez, R. Y., Alayo, N., Novi, G., Quinteros, C., Kaya, F., Zimmerman, M. D., Caceres, D. H., et al. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012521 · Cited by 11 · see citing works
Microbe Profile: Candida glabrata – a master of deception
Granada, M., Cook, E., Sherlock, G. J., & Rosenzweig, F. (2024) · Microbiology · doi:10.1099/mic.0.001518 · Cited by 10 · see citing works
Langsiri, N., Meyer, W., Irinyi, L., Worasilchai, N., Pombubpa, N., Wongsurawat, T., Jenjaroenpun, P., Luangsa-ard, J. J., & Chindamporn, A. (2025) · mSystems · doi:10.1128/msystems.01166-24 · Cited by 10 · see citing works
Rinker, D. C., Sauters, T. J. C., Steffen, K., Gumilang, A., Raja, H. A., Rangel‐Grimaldo, M., Pinzan, C. F., de Castro, P. A., dos Reis, T. F., Delbaje, E., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-06756-8 · Cited by 10 · see citing works
Asadzadeh, M., Ahmad, S., Al‐Sweih, N., & Khan, Z. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1242622 · Cited by 7 · see citing works
Microevolution of Candida glabrata (Nakaseomyces glabrata) during an infection
López-Marmolejo, A. L., Hernández-Chávez, M. J., Gutiérrez‐Escobedo, G., Herrera-Basurto, M. S., Mora-Montes, H. M., Peñas, A. D. L., & Castaño, I. (2024) · Fungal Genetics and Biology · doi:10.1016/j.fgb.2024.103891 · Cited by 6 · see citing works
ATR-FTIR spectroscopic markers indicating drug resistance in selected Candida strains
Dróźdż, A., Kubera, D., Olender, A., Dąbrowski, W., Szukała, M., Wośko, S., Chwiej, J. G., Rugiel, M. M., Kawon, K. K., & Gagoś, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-01428-x · Cited by 7 · see citing works
New approaches to tackle a rising problem: Large-scale methods to study antifungal resistance
Després, P. C., Shapiro, R. S., & Cuomo, C. A. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012478 · Cited by 6 · see citing works
Hwang, I. J., Kwon, Y. J., Lim, H. J., Hong, K. H., Lee, H., Yong, D., Won, E. J., Byun, S. A., Lee, G. Y., Kim, S. H., et al. (2024) · Microbiology Spectrum · doi:10.1128/spectrum.00883-24 · Cited by 5 · see citing works
Walworth, N. G., Espinoza, J. L., Argyle, P., Hinners, J., Levine, N. M., Doblin, M. A., Dupont, C. L., & Collins, S. (2023) · Molecular Biology and Evolution · doi:10.1093/molbev/msad218 · Cited by 5 · see citing works
Self-citationEvaluation of the Eazyplex® Candida ID LAMP Assay for the Rapid Diagnosis of Positive Blood Cultures
Berlau, A., Stoll, S., Edel, B., Löffler, B., & Rödel, J. (2024) · Diagnostics · doi:10.3390/diagnostics14192125 · Cited by 6 · see citing works
Luca, D. G. D., Alexander, D. C., Dingle, T. C., Dufresne, P. J., Fuller, J., German, G. J., Haldane, D. J. M., Hoang, L., Jiao, L., Kus, J. V., et al. (2025) · Microbiology Spectrum · doi:10.1128/spectrum.01803-25 · Cited by 3 · see citing works
Nakano, K., Okamoto, M., Takahashi‐Nakaguchi, A., Sasamoto, K., Yamaguchi, M., & Chibana, H. (2023) · Journal of Fungi · doi:10.3390/jof9101035 · Cited by 3 · see citing works
Soriano-Abarca, M., Tapia, J. C., Cáceres-Valdiviezo, M. J., Gabriel Morey-León, G., Fernández‐Cadena, J. C., Díaz-Cevallos, L., & Andrade-Molina, D. (2024) · Microbial Physiology · doi:10.1159/000540991 · Cited by 3 · see citing works
Maroc, L., Shaker, H., & Shapiro, R. S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.12.07.569977 · Cited by 3 · see citing works
Community-Wide Genotyping of Batrachochytrium dendrobatidis in Ecuadorian Forests
Neely, W. J., Moretta-Urdiales, M., Smart, U., Lynch, R. L., Guayasamin, J. M., McCracken, S. F., & Rodríguez, D. (2025) · EcoHealth · doi:10.1007/s10393-025-01716-y · Cited by 2 · see citing works
Fleres, G., Cheng, S., Badrane, H., Dupont, C. L., Espinoza, J. L., Abbey, D., Driscoll, E., Newbrough, A., Hao, B., Mansour, A., et al. (2025) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaf495 · Cited by 2 · see citing works
Self-citation“Should I stay or should I go”—a kinase delays escape of Candida glabrata from macrophages
Lange, T., Clairet, C., Fischer, L., Vij, R., Sonnberger, J., Mantke, J., Jablonowski, N., Seemann, E. A., Qualmann, B., d’Enfert, C., et al. (2026) · mBio · doi:10.1128/mbio.03885-25 · Cited by 2 · see citing works
Is metabolic generalism the Breakfast of Champions for pathogenic Candida species?
Childers, D. S., & Usher, J. (2024) · PLoS Pathogens · doi:10.1371/journal.ppat.1012752 · Cited by 2 · see citing works
Fleres, G., Cheng, S., Badrane, H., Dupont, C. L., Espinoza, J. L., Abbey, D., Driscoll, E., Newbrough, A., Hao, B., Mansour, A., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.16.618724 · Cited by 2 · see citing works
Self-citationImplication of genotypes for prognosis of Candida glabrata bloodstream infections
Chen, P., Huang, Y., Chuang, Y., Wang, J., Sheng, W., Chen, Y., & Chang, S. (2024) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkae200 · Cited by 1 · see citing works
Bukari, A.-R. A., Kukurudz-Gorowski, R., de Graaf, A., Habon, D. A., Manyaz, B., Syvolos, Y., Sumanarathnea, A., Poliquin, V., & Gerstein, A. C. (2025) · mSystems · doi:10.1128/msystems.00157-25 · Cited by 1 · see citing works
Fungal DNA‐barcoding on a chip: Magnetoresistive biosensors for yeast infection diagnosis
Zolotareva, M., Cascalheira, F., Afonso, R., Corado, M., Martins, A., Caneiras, C. S. G., Bárbara, C., Teixeira, M. C., & Caetano, D. M. (2025) · Open Research (University of Surrey) · doi:10.1002/viw.20250015 · Cited by 1 · see citing works
de Oliveira, R. M. V. V., Carvalho, A. R., da Silva, P. M., Ferreira, G. R. S., Amorim, P. K., Paiva, P. M. G., da Silva, L. C. N., Patriota, L. L. D. S., Pontual, E. V., & Napoleão, T. H. (2025) · Macromol—A Journal of Macromolecular Research · doi:10.3390/macromol5040044 · Cited by 1 · see citing works
Silva, M. M. P., Fernandes, M. Z., Moura, S., Esteves, A. S., Oliveira, A. S., Gaspar, C., Martinez‐de‐Oliveira, J., Palmeira-de-Oliveira, A., & Rolo, J. (2026) · Journal of Fungi · doi:10.3390/jof12020106 · Cited by 1 · see citing works
Zhao, Y.-Y., Dai, R.-C., Liu, F.-Y., Liu, K., Kang, W., Zhang, G., Li, J., Zhang, J.-J., Wang, T., Gao, H.-T., et al. (2026) · Emerging Microbes and Infections · doi:10.1080/22221751.2026.2695535 · Cited by 1 · see citing works
Ledesma, V., Vanbaelen, T., Gestels, Z., Panis, N., Abdellati, S., de Block, T., Baetselier, I. D., den Bossche, D. V., Manoharan-Basil, S. S., & Kenyon, C. R. (2024) · FEMS Microbiology Letters · doi:10.1093/femsle/fnae104 · Cited by 1 · see citing works
Strain heterogeneity in a non-pathogenic fungus highlights factors contributing to virulencePreprint
Rinker, D. C., Sauters, T. J. C., Steffen, K., Gumilang, A., Raja, H. A., Rangel‐Grimaldo, M., Pinzan, C. F., de Castro, P. A., dos Reis, T. F., Delbaje, E., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.08.583994 · Cited by 1 · see citing works
Johnson, Z., Nadim, F., & Zubko, M. K. (2025) · Microorganisms · doi:10.3390/microorganisms13010099
Sucu, M., Ünal, N., Karakoyun, A. S., Şahin, İ. N., Bingöl, O., Hüner, F., Uzay, F. İ., Ünal, İ., Metin, D. Y., & İlkit, M. (2025) · Journal of Fungi · doi:10.3390/jof11020092
Promising Role of Fruitless Wolfberry Bud Tea in Combating Nakaseomyces glabratus Resistance
Zhang, L., Ma, Z., Zhou, X., Zhang, Z., & Wu, T. (2025) · Pathogens · doi:10.3390/pathogens14040351
Yao, D., Chen, J., & Zhang, G. (2025) · Infection and Drug Resistance · doi:10.2147/idr.s510389
Strain Typing (Bacterial, Viral, Fungal, and Mycobacterial)
Seth-Smith, H. M. B., Rooney, A. M., & Egli, A. (2025) · Wiley eBooks · doi:10.1002/9781683674597.ch4
Scott, N. E., Zhou, X., Wash, E., Zajac, C., Kline, S. E., Erayil, S. E., & Selmecki, A. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.10.27.684856
Scott, N. E., Zhou, X., Wash, E., Zajac, C., Kline, S. E., Erayil, S. E., & Selmecki, A. M. (2026) · Microbial Genomics · doi:10.1099/mgen.0.001659
Highly sensitive and species-specific molecular detection of microbial pathogens
Hernández-Chávez, M. J., Juárez‐Reyes, A., Peñas, A. D. L., Merino, E., & Castaño, I. (2026) · Journal of Microbiological Methods · doi:10.1016/j.mimet.2026.107601
López-Marmolejo, A. L., Hernández-Chávez, M. J., Gutiérrez‐Escobedo, G., Varela‐Castillo, P., Herrera-Basurto, M. S., Martínez‐Gamboa, R. A., González-Lara, M. F., Sifuentes‐Osornio, J., Peñas, A. D. L., & Castaño, I. (2026) · Medical Mycology · doi:10.1093/mmy/myag077
Gómez-Gaviria, M., Ramírez-Sotelo, U., & Mora-Montes, H. M. (2026) · Current Clinical Microbiology Reports · doi:10.1007/s40588-026-00278-z
Dayal, D., Chaubey, K. K., Jayaswal, R. P., Rizvi, S. M. D., & Vyas, A. (2026) · Current Microbiology · doi:10.1007/s00284-026-05165-w
Sequential Time to Positivity as a Prognostic Indicator in Persistent Candidemia
Albanell‐Fernández, M., Vergara, A., Bodro, M., Espasa, M., Juan, P., Mensa, J., Tuset, M., Herrera, S., & Soriano, A. (2026) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofag619
- Authors
- Badrane, H., Cheng, S., Dupont, C., Hao, B., Driscoll, E., Morder, K., Liu, G., Newbrough, A., Fleres, G., Kaul, D., Espinoza, J., Clancy, C., & Nguyen, M. H.
- Affiliations
- University of Pittsburgh (US)
- J. Craig Venter Institute
- University of Pittsburgh
- J. Craig Venter Institute (US)
- Corresponding author
- Nguyen, Minh Hong
- ORCID
- Venue
- Nature Communications
- Published
- 2023-04-03
- Volume
- 14
- Issue
- 1
- Pages
- 5918-5918
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC10104189
- OpenAlex
- W4386968272
- Cited by
- 48
- References
- 69
- Citations by year
- 2026: 9 · 2025: 17 · 2024: 17 · 2023: 5
- FWCI
- 9.88
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Nature Communications (publishedVersion, cc-by)
- Research Square (acceptedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. Department of Health and Human Services (1U54GH009824)
- U.S. Department of Veterans Affairs (1I01BX001955, I01 BX001955)
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases (R21AI152018, R21AI160098, 1R01AI170111-01)
- University of Pittsburgh (SCR 022735, S10OD028483)
- York University
- National Institutes of Health (1U54GH009824, 1s10od028483-01a1)
- Center for Research Computing, University of Pittsburgh (SCR_022735)
- National Human Genome Research Institute (U54HG009824)
- National Institute of Allergy and Infectious Diseases (R21AI152018, R21AI160098, R01AI170111)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Yeasts and Rust Fungi Studies
- Keywords
- Candida glabrata, bloodstream infection, genotypic diversity, antifungal resistance, fluconazole resistance, clonal populations, phagocytosis, small colony variants, virulence attenuation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review